Josh Stanton and Michael Epton Respiratory Physiology Laboratory, Canterbury Respiratory Research Group Christchurch Hospital

Similar documents
Clinical pulmonary physiology. How to report lung function tests

Approach to CPET. CPET Cases. Case 1 4/4/2018. Impaired? Cardiac factors? Ventilatory factors?

Exercise Stress Testing: Cardiovascular or Respiratory Limitation?

Cardiopulmonary Exercise Testing Cases

PFT Interpretation and Reference Values

CTED and the Value of Exercise Testing

PULMONARY FUNCTION TESTING. Purposes of Pulmonary Tests. General Categories of Lung Diseases. Types of PF Tests

Basics of Cardiopulmonary Exercise Test Interpretation. Robert Kempainen, MD Hennepin County Medical Center

CASE OF THE MONTH. Lung Disease in Rheumatoid Arthritis

Chapter 3. Pulmonary Function Study Assessments. Mosby items and derived items 2011, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.

Objective: Prepare NBRC candidate for CRT and WRT Content Outline

The role of Pulmonary function Testing In Interstitial lung disease in infants. [ ipft in child ]

Cardiopulmonary Exercise Testing: its principles, interpretation & application. DM Seminar Harshith

Clinical Study Bronchial Responsiveness in Patients with Restrictive Spirometry

Testing Clinical Implications

Basic approach to PFT interpretation. Dr. Giulio Dominelli BSc, MD, FRCPC Kelowna Respiratory and Allergy Clinic

Cardiopulmonary Exercise Testing

6- Lung Volumes and Pulmonary Function Tests

L esercizio fisico e le patologie cardiorespiratorie: dalla valutazione funzionale alla prescrizione. M. Guazzi

PULMONARY FUNCTION TEST(PFT)

TSANZ/ANZSRS meeting 31 Mar Clinical utility of CPET. Bhajan Singh MBBS FRACP PhD

The Role of CPET (cardiopulmonary exercise testing) in Assessing Lung Disease in CF

Spirometry. Obstruction. By Helen Grim M.S. RRT. loop will have concave appearance. Flows decreased consistent with degree of obstruction.

Credential Maintenance Program

Cardiopulmonary Exercise Test (CPET) Evaluation Report

Lung function in HIV infected adolescents on antiretroviral therapy in Cape Town, South Africa

Cardiopulmonary Exercise Testing in Cystic Fibrosis

What do pulmonary function tests tell you?

Dyspnea is a common exercise-induced

Guide to the interpretation of Cardiopulmonary Exercise Testing

"Acute cardiovascular responses to different types of exercise and in different populations"

PULMONARY FUNCTION TESTS

Cardiopulmonary Exercise Testing: Relevant But Underused

Ivana Nedeljkovic, M Ostojic, V Giga, V Stojanov, J Stepanovic, A Djordjevic Dikic, B Beleslin, M Nikolic, M Petrovic, D Popovic

Pulmonary Function Testing. Ramez Sunna MD, FCCP

Understanding Spirometry Spirometry Interpretation Workshop Saturday 13 August 2017

Pulmonary function and exercise capacity after lung resection

Pulmonary Function Technologists (PFT) Detailed Content Outline

Benefits of Combined Aerobic/Resistance/Inspiratory Muscle Training in Patients with Chronic Heart Failure. The Ideal Exercise Program for CHF?

Preoperative assessment for lung resection. RA Dyer

Pulmonary Function Testing

Coexistence of confirmed obstruction in spirometry and restriction in body plethysmography, e.g.: COPD + pulmonary fibrosis

Teacher : Dorota Marczuk Krynicka, MD., PhD. Coll. Anatomicum, Święcicki Street no. 6, Dept. of Physiology

I Can t Breathe! Physiology and Evaluation of the Dyspneic Patient. Christopher Parker, MD Pulmonology, Norman Regional Health Systems

SUMMARY. Applied exercise physiology in rehabilitation of children with cerebral palsy

Lung Pathophysiology & PFTs

Maximal cardiopulmonary testing has increased

Pathophysiology Department

Report Templates Available for EasyOne Pro (LAB) and Easy on-pc

بسم هللا الرحمن الرحيم

AEROBIC METABOLISM DURING EXERCISE SYNOPSIS

Pulmonary rehabilitation in severe COPD.

PULMONARY FUNCTION. VOLUMES AND CAPACITIES

Supplementary Online Content

End-tidal pressure of CO 2 and exercise performance in healthy subjects

PFIZER INC. THERAPEUTIC AREA AND FDA APPROVED INDICATIONS: See USPI.

Clinical exercise testing

Evaluation of Small Airways Disease in asthma medical research: Application of Structural Equation Modeling (SEM) and Latent Transition Analysis (LTA)

Association of Preoperative Spirometry with Cardiopulmonary Exercise Capacity and Postoperative Outcomes in Surgical Patients

Title : Adaptation to exercise

DLCO Webinar Q&A Dr. Christine Oropez answers post-presentation FAQs

SPIROMETRY METHOD. COR-MAN IN / EN Issue A, Rev INNOVISION ApS Skovvænget 2 DK-5620 Glamsbjerg Denmark

Effects of mitral valve surgery on static lung function

Interval versus continuous training in patients with severe COPD: a randomized clinical trial

Using Spirometry to Rule Out Restriction in Patients with Concomitant Low Forced Vital Capacity and Obstructive Pattern

Quality Assurance Mapping Your QC Program Equipment and Test Quality. Susan Blonshine RRT, RPFT, FAARC, AE-C

COMPARISON BETWEEN INTERCOSTAL STRETCH AND BREATHING CONTROL ON PULMONARY FUNCTION PARAMETER IN SMOKING ADULTHOOD: A PILOT STUDY

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

Lung Function Basics of Diagnosis of Obstructive, Restrictive and Mixed Defects

PULMONARY FUNCTION TESTING. By: Gh. Pouryaghoub. MD Center for Research on Occupational Diseases (CROD) Tehran University of Medical Sciences (TUMS)

Difference Between The Slow Vital Capacity And Forced Vital Capacity: Predictor Of Hyperinflation In Patients With Airflow Obstruction

Journal of the COPD Foundation

Content Indica c tion Lung v olumes e & Lung Indica c tions i n c paci c ties

Key words: exercise therapy; exercise tolerance; lung diseases; obstructive; oxygen consumption; walking

Asthma Management Introduction, Anatomy and Physiology

Study No.: Title: Rationale: Phase: Study Period Study Design: Centres: Indication: Treatment: Objectives : Primary Outcome/Efficacy Variable:

Utility of Lung Clearance Index (LCI) as a Noninvasive Marker of Deployment Lung Disease. Silpa Krefft, M.D., M.P.H. September 20, 2016

CIRCULAR INSTRUCTION REGARDING ESTABLISHMENT OF IMPAIRMENT DUE TO OCCUPATIONAL LUNG DISEASE FOR THE PURPOSES OF AWARDING PERMANENT DISABLEMENT

MASTER SYLLABUS C. Course Number and Title: RESP 2410 Respiratory Care Equipment/Procedures IV

The role of CPX testing in the rehabilitation of cardiac patients.

Prapaporn Pornsuriyasak, M.D. Pulmonary and Critical Care Medicine Ramathibodi Hospital

My Heart is not Alone: Lung Disease in the Adult with Congenital Heart Disease

The role of lung function testing in the assessment of and treatment of: AIRWAYS DISEASE

CHRONIC DISEASE PROGRESSION promotes a loss in

University of Alberta

Respiratory and cardiovascular adaptations to exercise

Lab 4: Respiratory Physiology and Pathophysiology

Increased difference between slow and forced vital capacity is associated with reduced exercise tolerance in COPD patients

SA XXXX Special Authority for Subsidy

Subject Index. Carbon monoxide (CO) disease effects on levels 197, 198 measurement in exhaled air 197 sources in exhaled air 197

Pulmonary Function Laboratory ATS Accreditation Are you prepared? Susan Blonshine RRT, RPFT, FAARC, AE-C

Exercise 7: Respiratory System Mechanics: Activity 1: Measuring Respiratory Volumes and Calculating Capacities Lab Report

Adverse effect of additional weight on exercise against gravity in patients with chronic obstructive airways disease

Increased oxygen pulse after lung volume reduction surgery is associated with reduced dynamic hyperinflation

Increased prevalence of expiratory flow limitation during exercise in children with bronchopulmonary dysplasia

FOLLOW-UP MEDICAL CARE OF SERVICE MEMBERS AND VETERANS CARDIOPULMONARY EXERCISE TESTING

Pulmonary Function Testing: Concepts and Clinical Applications. Potential Conflict Of Interest. Objectives. Rationale: Why Test?

European Journal of Preventive Cardiology

The clinical utility of cardiopulmonary exercise testing: results of a university hospital

Study on dynamical characteristics of electrocardiographic parameters during physical load

Transcription:

Josh Stanton and Michael Epton Respiratory Physiology Laboratory, Canterbury Respiratory Research Group Christchurch Hospital

Setting Scene Advancements in neonatal care over past 30 years has resulted in an increase in survivability of people born with Very Low Birth Weight (VLBW). Most data available during childhood and adolescence. Little is known about pulmonary function sequelae and exercise capacity in adult survivors of VLBW

FEV 1 Research in VLBW A.-M. Gibson, L.W. Doyle / Seminars in Fetal & Neonatal Medicine 19 (2014) 105-111

FEV 1 Research in VLBW A.-M. Gibson, L.W. Doyle / Seminars in Fetal & Neonatal Medicine 19 (2014) 105-111

Common Themes Spirometry A.-M. Gibson, L.W. Doyle / Seminars in Fetal & Neonatal Medicine 19 (2014) 105-111: Adapted from Tager et al, Am J Epidemiol 1979;110:15e26.

Common Themes Other lung function indices Decreased DLCO (Hakulinen, Vrijlandt) Increased gas trapping Exercise Capacity Mixed literature on maximal oxygen consumption reduced (Kilbride) no change cf age matched controls (Heldt, Vrijlandt) Reduced maximal WR (Vrijlandt) Reduced AT (Vrijlandt)

Aim To investigate the effect of VLBW on lung function and exercise capacity in young adult survivors.

Methods A multi-specialty research project involving New Zealand babies born in 1986 is in progress 250 VLBW (<1500g) 100 age matched term controls 2-day visit to Christchurch including: cardiac echo and ECG, Cranial MRI, psychometric testing, eye exam, dental exam, multiple questionnaires/interviews, blood test and respiratory function This presentation focuses on the respiratory physiology First 69 VLBW and 27 Controls

Methods Testing Regimen: Spirometry Diffusing capacity not corrected for Hb yet Lung volumes via plethysmography Sensormedics V62J autobox Tests conducted to ATS/ERS 2005 specifications

Methods Testing Regime: Spirometry Diffusing capacity not corrected for Hb yet Lung volumes via plethysmography Single breath Nitrogen Washout (SBN 2 ) Sensormedics Vmax 229 Tests conducted to ATS/ERS 2005 specifications

Methods Testing Regime: Spirometry Diffusing capacity not corrected for Hb yet Lung volumes via plethysmography Single breath Nitrogen Washout (SBN 2 ) Sensormedics Vmax 229 25% 75% Tests conducted to ATS/ERS 2005 specifications

Methods Testing Regime: Spirometry Diffusing capacity not corrected for Hb yet Lung volumes via plethysmography Single breath Nitrogen Washout (SBN 2 ) Symptom limited maximal cycle ergometer ramp protocol CPET 15-30 Watt.min -1 ramp Borg Scores 12 lead ECG Tests conducted to ATS/ERS 2005 specifications

Statistical methods Mann-Whitney U test for between group differences Fishers exact for contingency table p value < 0.05 considered significant Group results reported as median values +/- IQR

Results: Demographics 69 VLBW, (39 female) 27 Control (17 female) Age range 26-28 VLBW Control p value Height cm 168.5 (161-175) Weight kg 70.5 (58-89) BMI 24.7 (22-30) 168 (165-178) 77.5 (70-93) 27.1 (24-31) ns 0.04 ns Median (IQR) values reported

Respiratory Function Tests Spirometry (Hankinson 1999) Parameter VLBW Control p value FEV 1 % predicted 95.8 (86-105) 101.9 (94-106) 0.04 FVC % predicted 102.4 (95-110) 102.9 (95-108) ns FEV 1 /FVC % 78.3 (73-84) 83.7 (78-86) 0.01 Median (IQR) values reported

Respiratory Function Tests Spirometry Categorisation Smoking Status VLBW (n=68) Control (n=27) Normal 43 (63%) 23 (85%) Restricted 3 (4%) 1 (4%) Mild Obstruction 18 (26%) 3 (11%) VLBW (n=65) Control (n=27) Never 45 (69%) 18 (67%) Current 16 (25%) 7(26%) Ex 4 (6%) 2 (7%) Moderate Obstruction Moderately Severe Obstruction 3 (4%) 0 1 (1%) 0 Fishers exact test: normal vs abnormal p<0.05 n( %) values reported

Respiratory Function Tests DLCO (Cotes, 1993) Parameter VLBW Control p value DLCO % predicted 76.5 (69-85) 87.0 (75-93) 0.01 VA % predicted 92.9 (87-101) 93.0 (89-101) ns DLCO/VA 4.4 (4.1-4.8) 4.9 (4.4-5.2) 0.004 Median (IQR) values reported

Respiratory Function Tests Lung Volumes (Quanjer, 1993) Parameter VLBW Control p value TLC % predicted 98.5 (92-108) 97 (93-104) ns RV % predicted 70.8 (60-85) 61.3 (53-79) ns RV/TLC % 18.8 (16-23) 17.0 (15-21) ns Median (IQR) values reported

Single Breath N 2 Index of ventilation distribution Parameter VLBW Control p value Phase III slope 0.93 (0.72 1.24) 0.64 (0.53 0.85) 0.002 Median (IQR) values reported

Exercise Exercise capacity Parameter VLBW Control p value VO 2 % predicted 89 (80-99) 91 (77-109) ns WR % predicted 88 (78-99) 95 (83-110) ns VO 2 /WR slope 9.8 (9.3-10.6) 10 (9.4-10.5) ns AT (%pred VO 2 ) 49.7 (43-60) 60.8 (43-69) ns Median (IQR) values reported

Exercise Gas exchange Parameter VLBW Control p value VE/VCO 2 at AT 26 (25-28) 26 (25-27) ns VE/VO 2 at AT 27 (25-29) 27 (25-28) ns Delta SpO 2 (%) -1.0 (-2 to 0) 0 (-2 to 1) ns Median (IQR) values reported

Exercise Cardiovascular Parameter VLBW Control p value O 2 Pulse % predicted 101 (88-110) 104 (94-118) ns HRR (bpm) 17 (7-30) 24 (12-28) ns HR/VO 2 slope 3.5 (3.1-4.4) 3.7 (3.2-4.2) ns Ventilatory Parameter VLBW Control p value VE max % predicted 56 (46-65) 54 (44-62) ns Tidal Volume % pred 88.5 (76-97) 89 (78-95) ns RR max 36 (31-40) 37 (29-43) ns Median (IQR) values reported

Exercise Main reason for stopping exercise VLBW (n=65) Control (n=27) Dyspnoea 11 (17%) 2 (7%) Legs 42 (65%) 19 (70%) Both 5 (8%) 4 (15%) Other 7 (11%) 2 (7%) Borg Scores VLBW Control Borg Dyspnoea peak exercise (/10) 4 4 Borg Workload peak exercise (/10) 4 5 n( %) values reported Median values reported

Breathing Reserve (%) Reserves 80 70 60 50 40 30 20 10 0 Cardiac limited control VLBW HHR= Predicted HR (210-0.65 * age) Max HR BR (%) = (MVV-VE Max ) / MVV *100 Median peak RER in both groups 1.29-10 Ventilatory Limited -20-20 0 20 40 60 80 100 Heart Rate Reserve (beats)

Summary Persisting airway obstruction in the VLBW group into adulthood Reduced FEV 1 /FVC (78% vs 84%) Reduced FEV 1 (96% vs 102%predicted) Reduced DLCO (77% vs 87% predicted) in VLBW subjects No difference in exercise outcomes measured between the VLBW and Controls.

What s Next? Complete data collection Differentiate the cohort: with and without BPD/co-morbidities at birth gestational age gender differences DLCO Hb correction Continue with exercise data collection generate exercise reference equations for 27 year olds from our control data

What does lung function in early life predict in this group? A.-M. Gibson, L.W. Doyle / Seminars in Fetal & Neonatal Medicine 19 (2014) 105-111: Adapted from Tager et al, Am J Epidemiol 1979;110:15e26.

Acknowledgements Investigation team Brian Darlow John Horwood Julia Martin Mike Epton Maureen Swanney Josh Stanton Testing and Analysis Jun Yang Emily Ingram Fiona Fulton Lauren Wallace Maureen Swanney Josh Stanton